￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
In renal cell carcinoma, lenvatinib/pembrolizumab outperforms first-line standard

2026-02-01 22:25:32

Check Details
Lenvatinib/pembrolizuma shows sustained anti-tumor activity and extends survival in nccRCC

2026-02-01 22:25:32

Check Details
Analysis of anti-tumor effects and potential side effects of lenvatinib/lenvatinib

2026-02-01 22:25:32

Check Details
Is lenvatinib/lenvatinib available in capsules?

2026-02-01 22:25:32

Check Details
Lenvatinib/lenvatinib belongs to several generations of targeted drugs

2026-02-01 22:25:32

Check Details
Can lenvatinib/lenvatinib be taken on and off for 21 days and 7 days?

2026-02-01 22:25:32

Check Details
Which manufacturer of lenvatinib/lenvatinib is better?

2026-02-01 22:25:32

Check Details
Is taking one pill of lenvatinib/lenvatinib a day effective?

2026-02-01 22:25:32

Check Details
Lenvatinib/Lenvatinib Capsules: Existing form, mechanism of action and medication guidance

2026-02-01 22:25:32

Check Details
Lenvatinib/lenvatinib: Characteristics and applications of third-generation targeted antitumor drugs

2026-02-01 22:25:32

Check Details
Lenvatinib/lenvatinib medication cycle: Can I stop for 7 days after taking it for 21 days?

2026-02-01 22:25:32

Check Details
Overview of the latest selling price and efficacy of lorlatinib in 2024

2026-02-01 22:25:32

Check Details
Category
相关知识